Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Odronextamab for B-Cell Lymphoma
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial is testing a new antibody to treat several types of lymphoma that have relapsed or are resistant to other treatments. The primary goal is to see if the antibody shrinks tumors. Secondary goals are to see if the antibody prolongs progression-free survival, overall survival, and duration of response, and to assess the antibody's safety and tolerability.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.